{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:33:09Z","timestamp":1790353989848,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T00:00:00Z","timestamp":1694217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T00:00:00Z","timestamp":1694217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the Chinese National Natural Science Foundation","doi-asserted-by":"crossref","award":["81441086"],"award-info":[{"award-number":["81441086"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the Chinese National Natural Science Foundation","doi-asserted-by":"crossref","award":["81672976"],"award-info":[{"award-number":["81672976"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY14H160016"],"award-info":[{"award-number":["LY14H160016"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Health Science and Technology Project of Zhejiang Provincial Health Commission","award":["2017RC006"],"award-info":[{"award-number":["2017RC006"]}]},{"name":"Medical Health Science and Technology Project of Zhejiang Provincial Health Commission","award":["2018RC049"],"award-info":[{"award-number":["2018RC049"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Radiol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s11604-023-01482-3","type":"journal-article","created":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T01:01:56Z","timestamp":1694221316000},"page":"102-108","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Inflammation index predicts radiation-induced lung injury and prognosis in lung tumors treated with stereotactic body radiation therapy"],"prefix":"10.1007","volume":"42","author":[{"given":"Jingjing","family":"Shan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benxing","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,9]]},"reference":[{"issue":"6","key":"1482_CR1","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1378\/chest.12-0790","volume":"142","author":"J Donington","year":"2012","unstructured":"Donington J, Ferguson M, Mazzone P, Handy J Jr, Schuchert M, Fernando H, et al. American College of Chest Physicians and Society of Thoracic Surgeons consensus statement for evaluation and management for high-risk patients with stage I non-small cell lung cancer. Chest. 2012;142(6):1620\u201335.","journal-title":"Chest"},{"issue":"4","key":"1482_CR2","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1053\/j.seminoncol.2018.06.002","volume":"45","author":"A Shinde","year":"2018","unstructured":"Shinde A, Li R, Kim J, Salgia R, Hurria A, Amini A. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer in the elderly. Semin Oncol. 2018;45(4):210\u20139.","journal-title":"Semin Oncol"},{"issue":"1","key":"1482_CR3","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1016\/j.cllc.2018.09.004","volume":"20","author":"CA Schonewolf","year":"2019","unstructured":"Schonewolf CA, Heskel M, Doucette A, Singhal S, Frick MA, Xanthopoulos EP, et al. Five-year long-term outcomes of stereotactic body radiation therapy for operable versus medically inoperable stage I non-small-cell lung cancer: analysis by operability, fractionation regimen, tumor size, and tumor location. Clin Lung Cancer. 2019;20(1):e63\u201371.","journal-title":"Clin Lung Cancer"},{"key":"1482_CR4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.radonc.2019.01.027","volume":"134","author":"BH Kann","year":"2019","unstructured":"Kann BH, Verma V, Stahl JM, Ross R, Dosoretz AP, Shafman TD, et al. Multi-institutional analysis of stereotactic body radiation therapy for operable early-stage non-small cell lung carcinoma. Radiother Oncol. 2019;134:44\u20139.","journal-title":"Radiother Oncol"},{"issue":"6","key":"1482_CR5","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s11547-018-0858-7","volume":"123","author":"V Figlia","year":"2018","unstructured":"Figlia V, Mazzola R, Cuccia F, Alongi F, Mortellaro G, Cespuglio D, et al. Hypo-fractionated stereotactic radiation therapy for lung malignancies by means of helical tomotherapy: report of feasibility by a single-center experience. Radiol Med. 2018;123(6):406\u201314.","journal-title":"Radiol Med"},{"issue":"2","key":"1482_CR6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.radonc.2018.07.001","volume":"129","author":"JH Chang","year":"2018","unstructured":"Chang JH, Poon I, Erler D, Zhang L, Cheung P. The safety and effectiveness of stereotactic body radiotherapy for central versus ultracentral lung tumors. Radiother Oncol. 2018;129(2):277\u201383.","journal-title":"Radiother Oncol"},{"key":"1482_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1748-717X-2-21","volume":"2","author":"H Yamashita","year":"2007","unstructured":"Yamashita H, Nakagawa K, Nakamura N, Koyanagi H, Tago M, Igaki H, et al. Exceptionally high incidence of symptomatic grade 2\u20135 radiation pneumonitis after stereotactic radiation therapy for lung tumors. Radiat Oncol. 2007;2:21.","journal-title":"Radiat Oncol"},{"issue":"3","key":"1482_CR8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.radonc.2009.02.003","volume":"91","author":"GR Borst","year":"2009","unstructured":"Borst GR, Ishikawa M, Nijkamp J, Hauptmann M, Shirato H, Onimaru R, et al. Radiation pneumonitis in patients treated for malignant pulmonary lesions with hypofractionated radiation therapy. Radiother Oncol. 2009;91(3):307\u201313.","journal-title":"Radiother Oncol"},{"issue":"1","key":"1482_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.radonc.2010.04.027","volume":"97","author":"M Guckenberger","year":"2010","unstructured":"Guckenberger M, Baier K, Polat B, Richter A, Krieger T, Wilbert J, et al. Dose-response relationship for radiation-induced pneumonitis after pulmonary stereotactic body radiotherapy. Radiother Oncol. 2010;97(1):65\u201370.","journal-title":"Radiother Oncol"},{"issue":"1","key":"1482_CR10","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.ijrobp.2010.08.056","volume":"82","author":"RB Barriger","year":"2012","unstructured":"Barriger RB, Forquer JA, Brabham JG, Andolino DL, Shapiro RH, Henderson MA, et al. A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2012;82(1):457\u201362.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"1482_CR11","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.radonc.2011.04.002","volume":"99","author":"MC Stauder","year":"2011","unstructured":"Stauder MC, Macdonald OK, Olivier KR, Call JA, Lafata K, Mayo CS, et al. Early pulmonary toxicity following lung stereotactic body radiation therapy delivered in consecutive daily fractions. Radiother Oncol. 2011;99(2):166\u201371.","journal-title":"Radiother Oncol"},{"issue":"7","key":"1482_CR12","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/imj.12453","volume":"44","author":"HL Martin","year":"2014","unstructured":"Martin HL, Ohara K, Kiberu A, Van Hagen T, Davidson A, Khattak MA. Prognostic value of systemic inflammation-based markers in advanced pancreatic cancer. Intern Med J. 2014;44(7):676\u201382.","journal-title":"Intern Med J"},{"key":"1482_CR13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.critrevonc.2018.09.016","volume":"132","author":"RD Dolan","year":"2018","unstructured":"Dolan RD, Laird BJA, Horgan PG, McMillan DC. The prognostic value of the systemic inflammatory response in randomised clinical trials in cancer: a systematic review. Crit Rev Oncol Hematol. 2018;132:130\u20137.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1482_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.breast.2018.12.014","volume":"44","author":"V Graziano","year":"2019","unstructured":"Graziano V, Grassadonia A, Iezzi L, Vici P, Pizzuti L, Barba M, et al. Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients. Breast. 2019;44:33\u20138.","journal-title":"Breast"},{"issue":"4","key":"1482_CR15","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/bjc.2012.292","volume":"107","author":"MJ Proctor","year":"2012","unstructured":"Proctor MJ, McMillan DC, Morrison DS, Fletcher CD, Horgan PG, Clarke SJ. A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer. Br J Cancer. 2012;107(4):695\u20139.","journal-title":"Br J Cancer"},{"issue":"21","key":"1482_CR16","doi-asserted-by":"publisher","first-page":"5409","DOI":"10.1088\/0031-9155\/51\/21\/002","volume":"51","author":"T Nishio","year":"2006","unstructured":"Nishio T, Kunieda E, Shirato H, Ishikura S, Onishi H, Tateoka K, et al. Dosimetric verification in participating institutions in a stereotactic body radiotherapy trial for stage I non-small cell lung cancer: Japan clinical oncology group trial (JCOG0403). Phys Med Biol. 2006;51(21):5409\u201317.","journal-title":"Phys Med Biol"},{"issue":"9255","key":"1482_CR17","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","volume":"357","author":"F Balkwill","year":"2001","unstructured":"Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357(9255):539\u201345.","journal-title":"Lancet"},{"issue":"7","key":"1482_CR18","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s10147-020-01670-5","volume":"25","author":"Y Sun","year":"2020","unstructured":"Sun Y, Huang Z, Chi P. An inflammation index-based prediction of treatment response to neoadjuvant chemoradiotherapy for rectal mucinous adenocarcinoma. Int J Clin Oncol. 2020;25(7):1299\u2013307.","journal-title":"Int J Clin Oncol"},{"key":"1482_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.907625","volume":"12","author":"S Wang","year":"2022","unstructured":"Wang S, Yang X, Yu Z, Du P, Sheng X, Cao Y, et al. The values of systemic immune-inflammation index and neutrophil-lymphocyte ratio in predicting biochemical recurrence in patients with localized prostate cancer after radical prostatectomy. Front Oncol. 2022;12: 907625.","journal-title":"Front Oncol"},{"issue":"3","key":"1482_CR20","doi-asserted-by":"publisher","first-page":"576","DOI":"10.21037\/gs-22-117","volume":"11","author":"R Han","year":"2022","unstructured":"Han R, Tian Z, Jiang Y, Guan G, Sun X, Yu Y, et al. Prognostic significance of systemic immune-inflammation index and platelet-albumin-bilirubin grade in patients with pancreatic cancer undergoing radical surgery. Gland Surg. 2022;11(3):576\u201387.","journal-title":"Gland Surg"},{"issue":"3","key":"1482_CR21","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1007\/s11605-019-04187-z","volume":"24","author":"G Jomrich","year":"2020","unstructured":"Jomrich G, Gruber ES, Winkler D, Hollenstein M, Gnant M, Sahora K, et al. Systemic immune-inflammation index (sii) predicts poor survival in pancreatic cancer patients undergoing resection. J Gastrointest Surg. 2020;24(3):610\u20138.","journal-title":"J Gastrointest Surg"},{"issue":"2","key":"1482_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/0284186X.2021.2022201","volume":"61","author":"A Abravan","year":"2022","unstructured":"Abravan A, Salem A, Price G, Faivre-Finn C, van Herk M. Effect of systemic inflammation biomarkers on overall survival after lung cancer radiotherapy: a single-center large-cohort study. Acta Oncol. 2022;61(2):163\u201371.","journal-title":"Acta Oncol"},{"issue":"3","key":"1482_CR23","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1245\/s10434-019-08094-0","volume":"27","author":"P Murthy","year":"2020","unstructured":"Murthy P, Zenati MS, Al Abbas AI, Rieser CJ, Bahary N, Lotze MT, et al. Prognostic value of the systemic immune-inflammation index (SII) after neoadjuvant therapy for patients with resected pancreatic cancer. Ann Surg Oncol. 2020;27(3):898\u2013906.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"1482_CR24","doi-asserted-by":"publisher","first-page":"182","DOI":"10.7150\/jca.21703","volume":"9","author":"H Luo","year":"2018","unstructured":"Luo H, Ge H, Cui Y, Zhang J, Fan R, Zheng A, et al. Systemic inflammation biomarkers predict survival in patients of early stage non-small cell lung cancer treated with stereotactic ablative radiotherapy\u2014a single center experience. J Cancer. 2018;9(1):182\u20138.","journal-title":"J Cancer"},{"issue":"10","key":"1482_CR25","doi-asserted-by":"publisher","first-page":"5333","DOI":"10.21873\/anticanres.11106","volume":"36","author":"N Shaverdian","year":"2016","unstructured":"Shaverdian N, Wang J, Levin-Epstein R, Schaue D, Kupelian P, Lee P, et al. Pro-inflammatory state portends poor outcomes with stereotactic radiosurgery for brain metastases. Anticancer Res. 2016;36(10):5333\u20137.","journal-title":"Anticancer Res"},{"issue":"42","key":"1482_CR26","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000022603","volume":"99","author":"X Wang","year":"2020","unstructured":"Wang X, Lou Z, Zhang L, Liu Z, Zhang J, Gao J, et al. Evaluation of the prognostic value of derived neutrophil\/lymphocyte ratio in early stage non-small cell lung cancer patients treated with stereotactic ablative radiotherapy. Medicine (Baltimore). 2020;99(42): e22603.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"1482_CR27","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/JTO.0000000000000399","volume":"10","author":"NA Cannon","year":"2015","unstructured":"Cannon NA, Meyer J, Iyengar P, Ahn C, Westover KD, Choy H, et al. Neutrophil-lymphocyte and platelet-lymphocyte ratios as prognostic factors after stereotactic radiation therapy for early-stage non-small-cell lung cancer. J Thorac Oncol. 2015;10(2):280\u20135.","journal-title":"J Thorac Oncol"},{"issue":"4","key":"1482_CR28","doi-asserted-by":"publisher","first-page":"e362","DOI":"10.3747\/co.23.3051","volume":"23","author":"M Giuliani","year":"2016","unstructured":"Giuliani M, Sampson LR, Wong O, Gay J, Le LW, Cho BC, et al. Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes on outcomes in lung stereotactic body radiotherapy. Curr Oncol. 2016;23(4):e362\u20138.","journal-title":"Curr Oncol"},{"issue":"2","key":"1482_CR29","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3390\/diagnostics13020313","volume":"13","author":"B Dong","year":"2023","unstructured":"Dong B, Zhu X, Chen R, Wu Q, Jin J, Wang L, et al. Derived Neutrophil-lymphocyte ratio and c-reactive protein as prognostic factors for early-stage non-small cell lung cancer treated with stereotactic body radiation therapy. Diagnostics (Basel). 2023;13(2):313.","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"1482_CR30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3390\/curroncol29010019","volume":"29","author":"M Aduquaye","year":"2022","unstructured":"Aduquaye M, Dube S, Bashir B, Chowdhury A, Ahmed N, Leylek A, et al. Impact of pre-treatment nlr and other hematologic biomarkers on the outcomes of early-stage non-small-cell lung cancer treated with stereotactic body radiation therapy. Curr Oncol. 2022;29(1):193\u2013208.","journal-title":"Curr Oncol"},{"issue":"1","key":"1482_CR31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12890-020-1160-8","volume":"20","author":"JW Heo","year":"2020","unstructured":"Heo JW, Yeo CD, Park CK, Kim SK, Kim JS, Kim JW, et al. Smoking is associated with pneumonia development in lung cancer patients. BMC Pulm Med. 2020;20(1):117.","journal-title":"BMC Pulm Med"},{"issue":"5","key":"1482_CR32","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.adro.2020.06.023","volume":"5","author":"WB Harris","year":"2020","unstructured":"Harris WB, Zou W, Cheng C, Jain V, Teo BK, Dong L, et al. Higher dose volumes may be better for evaluating radiation pneumonitis in lung proton therapy patients compared with traditional photon-based dose constraints. Adv Radiat Oncol. 2020;5(5):943\u201350.","journal-title":"Adv Radiat Oncol"},{"issue":"2","key":"1482_CR33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.radonc.2004.02.015","volume":"71","author":"G Rodrigues","year":"2004","unstructured":"Rodrigues G, Lock M, D\u2019Souza D, Yu E, Van Dyk J. Prediction of radiation pneumonitis by dose\u2014volume histogram parameters in lung cancer\u2014a systematic review. Radiother Oncol. 2004;71(2):127\u201338.","journal-title":"Radiother Oncol"},{"issue":"1","key":"1482_CR34","doi-asserted-by":"publisher","first-page":"1701737","DOI":"10.1183\/13993003.01737-2017","volume":"51","author":"G Louvel","year":"2018","unstructured":"Louvel G, Bahleda R, Ammari S, Le P\u00e9choux C, Levy A, Massard C, et al. Immunotherapy and pulmonary toxicities: can concomitant immune-checkpoint inhibitors with radiotherapy increase the risk of radiation pneumonitis? Eur Respir J. 2018;51(1):1701737.","journal-title":"Eur Respir J"},{"issue":"8","key":"1482_CR35","doi-asserted-by":"publisher","first-page":"4347","DOI":"10.21037\/jtd-20-2137","volume":"12","author":"T Zhang","year":"2020","unstructured":"Zhang T, Bi N, Zhou Z, Chen D, Feng Q, Liang J, et al. The impact of age on the survival outcomes and risk of radiation pneumonitis in patients with unresectable locally advanced non-small cell lung cancer receiving chemoradiotherapy. J Thorac Dis. 2020;12(8):4347\u201356.","journal-title":"J Thorac Dis"}],"container-title":["Japanese Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-023-01482-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11604-023-01482-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-023-01482-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T18:12:21Z","timestamp":1704305541000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11604-023-01482-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,9]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["1482"],"URL":"https:\/\/doi.org\/10.1007\/s11604-023-01482-3","relation":{},"ISSN":["1867-1071","1867-108X"],"issn-type":[{"value":"1867-1071","type":"print"},{"value":"1867-108X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,9]]},"assertion":[{"value":"26 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of Sir Run Run Shaw Hospital. All patients signed informed consent for this study (Project number 20190927-1).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}